This is the standing evidence sheet for Biohaven (BHVN): the yardsticks BullScope computes from official SEC filings and market prices. It refreshes whenever a new edition of our research is published, and it is impersonal by design, every reader sees the same page. Nothing here is investment advice; it is the evidence, organized.
The price tag: what buyers pay per dollar of profit
The tape: what the stock itself has done
- Last price: $12.99 (end-of-day market data as of the edition date · methodology) · 28% below its 52-week high
- Past 6 months: +45.6% · past 12 months: -5.5%
- Day-to-day temperament: jumpy (annualized volatility 92%)
The road ahead: filed results vs published expectations
| FY2023A | FY2024A | FY2025A | FY2026E | FY2027E | |
|---|---|---|---|---|---|
| Net sales ($B) | 0.0 | 0.0 | 0.0 | 0.00 | 0.00 to 0.05 |
| Net sales growth (%) | NM | NM | NM | NM | NM |
| Operating income ($B) | -0.4 | -0.9 | -0.7 | -0.93 to -0.48 | -1.05 to -0.28 |
| R&D expense ($B) | 0.4 | 0.8 | 0.6 | 0.40 to 0.80 | 0.28 to 0.90 |
| Diluted EPS ($) | -5.73 | -9.28 | -6.86 | -9.50 to -5.00 | -12.00 to -3.00 |
Columns marked A are actual filed results; E columns are the published consensus ranges the current price is being weighed against.
The four gauges: from the latest edition
Read the full report on Biohaven in the BullScope Terminal → It opens with this company loaded.
Edition date: 2026-08-24. This page updates when a new edition is published. Sources: SEC EDGAR filings, Nasdaq prices; computed by BullScope’s published methodology.
BullScope publishes impersonal research for a general audience. Nothing here is personalized investment advice, and nothing here is a recommendation to buy or sell any security. As of publication, neither BullScope nor its operator holds a position in any security, covered or otherwise; we do not trade at all, and we accept no compensation from any company we cover. When a conflict of interest exists, we do not publish: companies that compensate our operator in any capacity, or about which our operator could hold nonpublic information, are barred from coverage automatically, as described in the conflicts policy in our methodology. Figures come from company filings and public data through our published methodology; forecasts are conditional scenarios, not predictions and not promises. Markets carry risk, including loss of principal. Consider your own situation, or consult a licensed adviser, before acting on anything you read.
